Pharmacology
News
“Terrific progress”: Adding blinatumomab for infant leukemia
Immunotherapy plus chemotherapy improves outcomes and may soon become first-line treatment for a rare pediatric blood cancer.
News
FDA puts partial hold on investigational alopecia areata drug deuruxolitinib
The announcement came after a pulmonary embolism occurred with the 12-mg twice-daily dose in one of the long-term open-label extension studies.
Conference Coverage
Statins tied to lower stroke risk in atrial fibrillation
Initiation of statins soon after diagnosis of AFib is associated with lower risk of ischemic and hemorrhagic strokes; longer-term use is tied to...
News
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
Conference Coverage
Medications provide best risk-to-benefit ratio for weight loss, says expert
Surgery provides the most weight loss, but has the greatest risk, according to an endocrinology, diabetes, and metabolism professor.
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
Conference Coverage
Pembrolizumab monotherapy effective for rare melanoma
Patients with unresectable desmoplastic melanoma experienced a response rate that was nearly double other melanomas.
News
AFib risk with cancer drugs underestimated
Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials.
Original Research
Assessment of IV Edaravone Use in the Management of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder that results in progressive...
Conference Coverage
Study gives new insight into timing of combo treatment in metastatic NSCLC
Best outcomes came when immunotherapy followed radiotherapy by 1-12 months.